These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17684763)

  • 21. [Associated gastroenteropancreatic neuroendocrine tumours to familiar syndromes].
    Lecumberri Pascual E
    Endocrinol Nutr; 2009 Apr; 56 Suppl 2():10-5. PubMed ID: 19627764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors.
    How-Kit A; Dejeux E; Dousset B; Renault V; Baudry M; Terris B; Tost J
    Epigenomics; 2015; 7(8):1245-58. PubMed ID: 26360914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Update of Neuroendocrine Tumors of the Female Reproductive System.
    Kefeli M; Usubütün A
    Turk Patoloji Derg; 2015; 31 Suppl 1():128-44. PubMed ID: 26177323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methyltransferases 1, 3a, and 3b overexpression and clinical significance in gastroenteropancreatic neuroendocrine tumors.
    Rahman MM; Qian ZR; Wang EL; Yoshimoto K; Nakasono M; Sultana R; Yoshida T; Hayashi T; Haba R; Ishida M; Okabe H; Sano T
    Hum Pathol; 2010 Aug; 41(8):1069-78. PubMed ID: 20381114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of echoendoscopy and scintigraphy of somatostatin receptors in the staging of neuro-endocrine digestive tumors].
    Giovannini M; Pasquier J; Brenot-Rossi I; Perrier H; Sauvan R; Seitz JF
    Ann Gastroenterol Hepatol (Paris); 1995; 31(2):109-13. PubMed ID: 7618832
    [No Abstract]   [Full Text] [Related]  

  • 26. Looking into digestive mixed neuroendocrine - nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors.
    Uccella S; La Rosa S
    Histopathology; 2020 Nov; 77(5):700-717. PubMed ID: 32538468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ENETS consensus guidelines for the management of patients with rare metastases from digestive neuroendocrine tumors: rationale and working framework. Introduction.
    O'Toole D; Rindi G; Plöckinger U; Wiedenmann B;
    Neuroendocrinology; 2010; 91(4):324-5. PubMed ID: 20407213
    [No Abstract]   [Full Text] [Related]  

  • 28. ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors.
    Kianmanesh R; Ruszniewski P; Rindi G; Kwekkeboom D; Pape UF; Kulke M; Sevilla Garcia I; Scoazec JY; Nilsson O; Fazio N; Lesurtel M; Chen YJ; Eriksson B; Cioppi F; O'Toole D;
    Neuroendocrinology; 2010; 91(4):333-40. PubMed ID: 20424420
    [No Abstract]   [Full Text] [Related]  

  • 29. ENETS consensus guidelines for the management of bone and lung metastases from neuroendocrine tumors.
    Kos-Kudła B; O'Toole D; Falconi M; Gross D; Klöppel G; Sundin A; Ramage J; Oberg K; Wiedenmann B; Komminoth P; Van Custem E; Mallath M; Papotti M; Caplin M;
    Neuroendocrinology; 2010; 91(4):341-50. PubMed ID: 20484875
    [No Abstract]   [Full Text] [Related]  

  • 30. Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin.
    Basu B; Sirohi B; Corrie P
    Endocr Relat Cancer; 2010 Mar; 17(1):R75-90. PubMed ID: 20008097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathological characteristics and clinical specifications in gastroenteropancreatic neuroendocrine tumors: a study of 68 cases.
    Stoica-Mustafa E; Pechianu C; Iorgescu A; Hortopan M; Dima SO; Tomulescu V; Dumitraşcu T; Ungureanu C; Andronesi D; Popescu I; Herlea V
    Rom J Morphol Embryol; 2012; 53(2):351-5. PubMed ID: 22732805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ENETS consensus guidelines for the management of brain, cardiac and ovarian metastases from neuroendocrine tumors.
    Pavel M; Grossman A; Arnold R; Perren A; Kaltsas G; Steinmüller T; de Herder W; Nikou G; Plöckinger U; Lopes JM; Sasano H; Buscombe J; Lind P; O'Toole D; Oberg K;
    Neuroendocrinology; 2010; 91(4):326-32. PubMed ID: 20453466
    [No Abstract]   [Full Text] [Related]  

  • 33. [Symptoms and diagnosis of neuroendocrine tumors of the digestive system].
    Gyökeres T
    Orv Hetil; 2011 Mar; 152(10):371-8. PubMed ID: 21354953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuroendocrine tumours of the alimentary tract--history and at present].
    Mandys V
    Cesk Patol; 2009 Jul; 45(3):57-63. PubMed ID: 19764158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of neuroendocrine tumors of the digestive tract].
    Wada I; Shimizu N; Seto Y
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1606-10. PubMed ID: 19838017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgery for gastroenteropancreatic neuroendocrine tumors (GEPNETS).
    Boudreaux JP
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):163-71, ix. PubMed ID: 21349417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract.
    Rindi G; Capella C; Solcia E
    Q J Nucl Med; 2000 Mar; 44(1):13-21. PubMed ID: 10932598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastroenteropancreatic endocrine tumors.
    Meeker A; Heaphy C
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):101-20. PubMed ID: 23906538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
    Toumpanakis CG; Caplin ME
    Am J Gastroenterol; 2008 Mar; 103(3):729-32. PubMed ID: 18341492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine diffuse system. Histological and functional aspects interrelated with tumoral pathology.
    Luca IC
    Rom J Morphol Embryol; 1998; 44(1-4):17-22. PubMed ID: 15678838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.